Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - Larimar Therapeutics, Inc. | d537290dex311.htm |
| EX-31.2 - EX-31.2 - Larimar Therapeutics, Inc. | d537290dex312.htm |
| 10-K - 10-K - Larimar Therapeutics, Inc. | d537290d10k.htm |
| EX-32.1 - EX-32.1 - Larimar Therapeutics, Inc. | d537290dex321.htm |
| EX-10.25 - EX-10.25 - Larimar Therapeutics, Inc. | d537290dex1025.htm |
| EX-10.24 - EX-10.24 - Larimar Therapeutics, Inc. | d537290dex1024.htm |
| EX-10.23 - EX-10.23 - Larimar Therapeutics, Inc. | d537290dex1023.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-219834) and Form S-8 (Nos. 333-210216, 333-196900, 333-204931 and 333-216602) of Zafgen, Inc. of our report dated March 9, 2018 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 9, 2018